SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 13, 2011
CRYO-CELL International, Inc.
(Exact name of registrant as specified in its charter)
| Delaware | 0-23386 | 22-3023093 | ||
| (State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) | ||
| 700 Brooker Creek Blvd., Suite 1800, Oldsmar, FL | 34677 | |||
| (Address of principal executive offices) | (Zip Code) | |||
Registrant’s telephone number, including area code: (813) 749-2100
Not applicable
(Former name or former address, if changed since last report)
Item 2.02. Results of Operations and Financial Condition.
The information in this Item is furnished to, but not filed with, the Securities and Exchange Commission (the “Commission”) solely under Item 12 of Form 8-K, “Results of Operations and Financial Condition.”
On July 13, 2011 Cryo-Cell International, Inc. issued a press release that included financial information for the three months ended May 31, 2011. A copy of the press release is furnished as Exhibit 99.1 to this report and is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
| (c) | Exhibits |
| 99.1 | Press Release dated July 13, 2011. |
-2-
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| CRYO-CELL INTERNATIONAL, INC. | ||||
| (Registrant) | ||||
| Date: July 13, 2011 | By: | /s/ Jill M. Taymans | ||
| Name: Jill M. Taymans | ||||
| Title: Vice President, Finance | ||||
-3-
EXHIBIT INDEX
| EXHIBIT |
EXHIBIT | |
| 99.1 | Press Release dated July 13, 2011. | |
-4-